Altamira Therapeutics Ltd (CYTO) stock is lower by -91.86% over the last 12 months. InvestorsObserver’s proprietary ranking system, gives CYTO stock a score of 18 out of a possible 100.
That rank is primarily influenced by a short-term technical score of 26. CYTO's rank also includes a long-term technical score of 27.
CYTO has an Overall Score of 18. Find out what this means to you and get the rest of the rankings on CYTO!
Altamira Therapeutics Ltd (CYTO) stock is trading at $2.15 as of 2:16 PM on Monday, Mar 25, a rise of $0.42, or 24.28% from the previous closing price of $1.73. Volume today is elevated. So far 60,185,872 shares have traded compared to average volume of 126,360 shares. The stock has traded between $2.10 and $3.49 so far today.
Click Here to get the full Stock Report for Altamira Therapeutics Ltd stock.
Share this article:
Stay In The Know
Subscribe to our daily morning update newsletter and never miss out on the need-to-know market news, movements, and more.
Thank you for signing up! You're all set to receive the Morning Update newsletter
